Learn more about Lori Porter, CEO and co-founder, National Association of Health Care Assistants, Carl Junction, MO.
5 plead guilty in massive nursing license scam
By
Jessica R. Towhey
May 17, 2023
Five defendants charged in the Florida nurse licensing scheme have pleaded guilty to wire fraud conspiracy. They each face up to 20 years in federal prison, authorities said.
Many LTC pill thefts still under the radar: study
By
Jessica R. Towhey
Jan 25, 2023
Nurses played a critical role in identifying the theft of more than 11,000 tablets from residents in nursing homes and assisted living facilities, investigators report.
Inaccurate pressure injury reporting compromises CMS safety ratings: study
Aug 12, 2022
Nursing home pressure injuries are widely underreported, casting doubt on a key measure of resident safety used in federal facility ratings, University of Chicago researchers say.
BREAKING: CMS issues details on vaccine mandate’s end
By
Kimberly Marselas
Jun 01, 2023
The Centers for Medicare & Medicaid Services on Wednesday afternoon issued a final rule lifting the COVID-19 vaccination mandate for healthcare workers by early August.
Cognitive evaluations must become routine in primary care, experts say
By
Alicia Lasek
Apr 19, 2023
“Sweeping changes” are needed to improve the rate of cognitive impairment detection by primary care providers, according to new recommendations from a workgroup of national experts.
Honoring the humble
By
Gary Tetz
Apr 10, 2023
Apparently, status is ultra-important to me. I just achieved elite standing on my favorite airline, and now I feel like a conquering hero as I move toward the front of the line and triumphantly stride...
Nursing home sector wants more help from hospitals in vaccination push
By
Joe Bush
Dec 20, 2022
Nursing home advocates are doubling down on their push to get hospitals that discharge so many patients to skilled nursing facilities to vaccinate those they’re transfering.
Dementia decline could be slowed by antiseizure meds in some cases, study finds
By
Alicia Lasek
Dec 05, 2022
The results revealed profound early decline among dementia patients with active seizures, including worse cognitive and mental health, and daily functioning.
BREAKING: FDA approves new experimental drug to treat early Alzheimer’s
By
Alicia Lasek
Jan 06, 2023
The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.